ICD E27.4ORPHA:869

Triple A Syndrome

Triple A syndrome, also called Allgrove syndrome, is a rare inherited condition caused by changes in the AAAS gene. It typically combines adrenal insufficiency, achalasia of the oesophagus and reduced tear production, and many people also develop nerve and autonomic problems over time. Management includes hormone replacement, treatment for swallowing difficulties, lubricating eye drops and neurological care.

117
Articles
Trials
Updated
18 September 2026
Loading...

Common Questions

What is Triple A Syndrome?

Triple A syndrome, also called Allgrove syndrome, is a rare inherited condition caused by changes in the AAAS gene. It typically combines adrenal insufficiency, achalasia of the oesophagus and reduced tear production, and many people also develop nerve and autonomic problems over time. Management includes hormone replacement, treatment for swallowing difficulties, lubricating eye drops and neurological care.

How many clinical trials are available for Triple A Syndrome?

No clinical trials are currently indexed for Triple A Syndrome. This may change as new trials are registered. Check back regularly or visit ClinicalTrials.gov directly.

Where does the research data for Triple A Syndrome come from?

RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is updated regularly by Rocky, RareWays' automated research engine. All articles and trials link directly to their original sources.

Get research updates

Monthly email when new findings are published for Triple A Syndrome.

No spam. Unsubscribe any time. Not medical advice.

This information is for general awareness only.

For guidance specific to your situation, please speak with your healthcare team.